RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S

Short Term Long Term Short Term Comparison Long Term Comparison

RTALB
1d1.41%
1w1.41%
1m-4.67%
1y45.14%
RTALB
1y45.14%
5y2,146.88%
10y0.00%
20y0.00%

Bitcoin
-0.82%
-9.09%
-6.40%
106.24%
Bitcoin
106.24%
1,146.32%
11,770.30%
0.00%

Ethereum
-0.90%
-11.75%
-14.49%
45.57%
Ethereum
45.57%
1,828.08%
0.00%
0.00%

Gold
0.26%
2.56%
11.41%
20.52%
Gold
20.52%
88.92%
85.82%
499.35%

Silver
0.47%
4.25%
15.38%
14.30%
Silver
14.30%
94.94%
48.08%
306.93%

Apple
-2.19%
1.78%
0.04%
5.09%
Apple
5.09%
260.11%
-66.73%
39,041.00%

Amazon
-1.68%
-1.44%
4.92%
78.52%
Amazon
78.52%
96.45%
-43.46%
7,943.96%

Microsoft
-1.96%
-2.97%
-0.67%
45.75%
Microsoft
45.75%
259.81%
923.86%
2,532.12%

S&P 500
-1.20%
-2.84%
-1.08%
22.34%
S&P 500
22.34%
74.12%
171.80%
346.13%

Dow & Jones
-0.65%
-2.95%
-2.53%
11.36%
Dow & Jones
11.36%
42.65%
129.74%
261.03%

ATH

ATH Price$26.99
ATH Date2020-08-31
% since ATH-54.60%
% to ATH120.29%

ATL

ATL Price$0.49
ATL Date2019-05-22
% from ATL2,384.28%
Last Low Price$5.7795
Last Low Date2022-06-13
% From Last Low111.96%

IPO

IPO Price$12.10
% Current ROI USD101.24%
ATH Price$26.99
% ROI ATH 547,258.16%

[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="RTALB"]

Key Data [addtoany]

Current price	$12.25
Sector	Healthcare
Industry	Biotechnology
Today's High/Low	$12.32/$11.93
Volume	1,033,356.00
Previous Close	$12.08
52 Week High/Low	$21.2/$6.5
Market Cap	1,224,999,936.00
P/E Ratio	4.9197
Forward P/E 1 Yr.	$0.00
Earnings Per Share(EPS)	$0
Annualized Dividend	$0

$12.25

[addtoany]

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey.
It offers microbiology products, including petri dish, tube and bottle, chromogenic media, blood culture bottle, tuberculosis diagnostic, rapid test, microbiological stain, hygislide, surcheck media, membrane, and swab products; and molecular biology products, such as nucleic acid isolation kits, real time PCR kits, and voltran viral load detection systems, as well as diagnovital SARS-CoV-2 multiple, a real-time RT-PCR-based test for the detection of the 2019 novel coronavirus.
The company was founded in 1996 and is based in Kocaeli, Turkey.

Annual Data \| Millions of US $ except per share data	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31
Cash on hand	-	-	-	-	-	-	-	-	-	-
Receivables	$6.76	$8.37	$14.42	$9.84	$9.36	$7.85	$5.50	$7.20	$4.65	$4.58
Inventory	$2.96	$3.87	$6.72	$9.12	$9.32	$8.39	$6.98	$5.20	$4.10	$2.31
Pre-Paid Expenses	-	-	-	-	-	-	-	-	-	-
Other Current Assets	$2.76	$3.98	$1.39	$1.51	$2.74	$1.42	$0.81	$0.86	$0.63	$0.51
Total Current Assets	$34.56	$32.86	$40.85	$37.44	$38.66	$36.22	-	-	-	-
Property, Plant, And Equipment	$14.78	$11.17	$9.48	$11.62	$10.06	$8.25	$8.06	$3.24	$1.84	$2.19
Long-Term Investments	$28.19	-	-	-	-	-	-	-	-	-
Goodwill And Intangible Assets	$0	$1.03	$1.03	$1.03	$1.03	-	-	-	-	-
Other Long-Term Assets	$20.50	$20.52	$11.67	$10.76	$11.70	$3.89	$3.95	$0.07	$0.29	$0.47
Total Long-Term Assets	$63.60	$33.19	$22.24	$23.46	-	-	-	-	-	-
Total Assets	$98.16	$66.05	$63.09	$60.89	$61.61	$49.04	$29.35	$20.45	$16.60	$16.86
Total Current Liabilities	$7.81	$8.66	$8.26	$9.28	$9.83	$9.73	$7.04	$8.96	$6.06	$4.99
Long Term Debt	$3.42	-	-	$0.15	$2.07	$0.34	-	$0.13	$0100000	$0.14
Other Non-Current Liabilities	$0.23	$0.33	$0.58	$1.27	$1.60	$0.46	$0.34	$0.36	$0.17	$0.14
Total Long Term Liabilities	$3.66	$0.33	$0.58	$1.41	-	-	-	-	-	-
Total Liabilities	$11.47	$8.99	$8.84	$10.69	$14.88	$11.40	$8.52	$9.46	$6.41	$5.39
Common Stock Net	$36.10	$23.60	$23.60	$5.90	$5.90	$5.90	$4.80	$4.80	$4.80	$4.80
Retained Earnings (Accumulated Deficit)	$30.83	$24.79	$24.65	$25.93	$22.78	$16.18	$11.58	$6.03	$4.45	$5.70
Comprehensive Income	-	-	-	-	-	-	-	-	-	-
Other Share Holders Equity	$18.23	$8.16	$4.95	$5.09	$5.12	$2.52	-	-	-	-
Share Holder Equity	$86.63	$57.91	$54.17	$49.92	$45.92	$36.73	$20.83	$11.88	$10.99	$11.85
Total Liabilities And Share Holders Equity	-	-	-	-	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31
Revenue	$16.77	$20.47	$38.45	$31.81	$33.68	$26.44	$18.66	$18.23	$16.75	$10.57
Cost Of Goods Sold	$12.49	$17.57	$25.63	$20	$18.50	$13.78	$8.33	$9.97	$9.11	$5.73
Gross Profit	-	-	-	-	-	-	-	-	-	-
Research And Development Expenses	$4.10	$3.57	$2.65	$1.61	$1.62	$1.49	$1.16	$0.86	$1.02	$0.48
SG&A Expenses	$2.63	$2.91	$2.42	$8.03	$7.06	$5.97	$2.99	$3.77	$3.44	$2.93
Other Operating Income Or Expenses	$-2.30	$-2.31	$-0.08	$-0.37	$0.05	$0.51	-	-	-	-
Operating Expenses	$19.67	$28.45	$35.72	$29.27	$27.23	$22.42	-	-	-	-
Operating Income	$-2.90	$-7.98	$2.73	$2.54	$6.45	$4.02	$3.47	$2.85	$3.34	$0.92
Total Non-Operating Income/Expense	-	-	-	-	-	-	-	-	-	-
Pre-Tax Income	$3.95	$-2.23	$4.36	$4.56	$9.07	$5.37	$5.08	$2.69	$1.94	$3.69
Income Taxes	$-0.62	$-1.50	$0.40	$1	$1.70	$0.81	$0.95	$0.43	$0.28	$0.63
Income After Taxes	$-0.62	$-1.50	$0.40	$1	$1.70	$0.81	$0.95	$0.43	$0.28	$0.63
Other Income	-	-	-	-	-	-	-	-	-	-
Income From Continuous Operations	$4.57	$-0.33	$3.96	$3.55	$7.38	$4.56	-	-	-	-
Income From Discontinued Operations	-	-	-	-	-	-	-	-	-	-
Net Income	$4.42	$0.60	$4.16	$4.09	$7.48	$4.54	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
EBIT	$-2.90	$-7.98	$2.73	$2.54	$6.45	$4.02	$3.47	$2.85	$3.34	$0.92
Basic Shares Outstanding	-	-	-	-	-	-	-	-	-	-
Shares Outstanding	-	-	-	-	-	-	-	-	-	-
Basic EPS	-	-	-	-	-	-	-	-	-	-
EPS - Earnings Per Share	-	-	-	-	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2019-12-31	2019-09-30	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31
Net Income/Loss	$4.42	-	$0.60	$4.16	$4.09	$7.48	$4.54	-	-	-	-
Total Depreciation And Amortization - Cash Flow	$1.50	-	$1.21	$1.54	$1.33	$0.77	$0.66	-	-	-	-
Change In Accounts Receivable	$0.66	-	$3.35	$-4.03	$-0.46	$-2.24	$-2.78	$2.27	-	-	-
Change In Inventories	$0.91	-	$2.85	$2.40	$0.20	$-0.94	$-1.41	-	-	-	-
Cash Flow From Operating Activities	$3.76	-	$-6.11	$1.41	$2.86	$6.18	$2.58	$11.26	$2.24	$1.61	$2.78
Cash Flow From Investing Activities	$-29.26	-	$-2.02	$-0.18	$-2.80	$-9.14	$-1.03	-	-	-	$0.38
Debt Issuance/Retirement Net - Total	$8.90	-	$-0.85	$0.02	$-2140600	$2.87	$0.59	-	-	-	-
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-	-	-	$-0.84	$-3.23	$-0.49
Financial Activities - Other	$-0.02	-	$-0.30	$0.09	$0.09	$-0.16	$0.93	$0.88	-	-	-
Cash Flow From Financial Activities	$31.73	-	$-1.15	$0.11	$-2140600	$2.71	$13.77	-	-	-	-
Net Cash Flow	$6.24	-	$-8.98	$1.33	$-1.95	$-0.24	$15.32	-	-	-	-
Common Stock Dividends Paid	-	-	-	-	-	-	-	-	$-0.84	$-3.23	$-0.49